All News

To change the physical characteristics of existing polymers for new market opportunities such as non-stick chewing gum.

As the countries of the European Union struggle to meet their targets for R&D growth, they are looking at new tax breaks for entrepreneurs. Good news, or too little too late?

Mary Lisbeth D'Amico's fortnightly funding column looks at the contenders for Europe’s premier exchange for growth stocks.

Steelmaker Arcelor, carmaker Daimler-Benz and some 50 companies are joining an effort by the French National Center for Scientific Research to form an education and research network to scout new metallic materials for industrial use.

Sigma-Aldrich, a US-based Nasdaq-listed life science company, has agreed to license a gene delivery technology from Oxford BioMedica and will pay $5 million for a stake in the spin out from Oxford University.

Take care: not all spin-outs end in fame and glory. The path from academia to industry is strewn with pitfalls…

Mary Lisbeth D'Amico's first fortnightly funding column reveals how coming out on top in a start-up talent show does not guarantee funding.

Scientists love to complicate things; and if you're not in the same field, or – worse – are in business or investment, then it's easy to get lost. Enter the Science|Business Quick Guides to some of the hottest fields of science and technology…

One of Europe’s biggest research organisations, Fraunhofer Gesellschaft in Germany, is pushing to close its first venture fund to finance spin-off companies from the institute.

Europe looks increasingly likely to follow America’s lead and require drug companies to test their products in children. But Europe's pharma lack the resources to carry out drug trials in children — so industry and patients will have to rely on the skills developed in academic centres.

IBM’s savvy move to share 500 patents may spark innovation in computer software and in how companies handle IP.